Strides Pharma Science Ltd (BOM:532531)
ā‚¹ 1634.5 39.35 (2.47%) Market Cap: 150.72 Bil Enterprise Value: 170.45 Bil PE Ratio: 64.92 PB Ratio: 6.62 GF Score: 68/100

Q2 2025 Strides Pharma Science Ltd Earnings Call Transcript

Oct 24, 2024 / 11:00AM GMT
Release Date Price: ā‚¹1534.65 (-1.54%)
Operator

Ladies and gentlemen, good day and welcome to Strides Pharma Science Limited Q2 and H1 FY25 earnings conference call. As a reminder, all participant lines will be in the listen-only mode and there will be an opportunity for you to ask questions after the presentation concludes. (Operator Instructions) Please note that this conference is being recorded.

I now hand the conference over to Mr. Abhishek Singhal. Thank you and over to you, sir.

Abhishek Singhal
Strides Pharma Science Ltd - Investor Relations

Thank you very good afternoon and thank you for joining us today for strides earnings call for the second quarter and half year ended financial year 2025.

Today we have with us, our own founder and executive Chairman Badree, Managing Director and Group CEO; and Vikesh Kumar, Group CFO to share the highlights of the business and financials for the quarter. I hope you've gone through our research and the quarterly minister position that have been uploaded on our website as well as Stock exchange website.

The transcript of this call

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investorsā€™ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot